Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

References for PMC Articles for PubMed (Select 17893044)

1.

Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.

Tebbi CK, London WB, Friedman D, Villaluna D, De Alarcon PA, Constine LS, Mendenhall NP, Sposto R, Chauvenet A, Schwartz CL.

J Clin Oncol. 2007 Feb 10;25(5):493-500.

2.

SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection.

Tan M, Gallegos JR, Gu Q, Huang Y, Li J, Jin Y, Lu H, Sun Y.

Neoplasia. 2006 Dec;8(12):1042-54.

3.

Targeting the short form of cFLIP by RNA interference is sufficient to enhance TRAIL sensitivity in PC3 prostate carcinoma cells.

White SJ, Lu P, Keller GM, Voelkel-Johnson C.

Cancer Biol Ther. 2006 Dec;5(12):1618-23. Epub 2006 Dec 5.

PMID:
17106251
4.

Caspase-8 dependent TRAIL-induced apoptosis in cancer cell lines is inhibited by vitamin C and catalase.

Perez-Cruz I, Cárcamo JM, Golde DW.

Apoptosis. 2007 Jan;12(1):225-34.

PMID:
17031493
5.

Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate.

Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu J, Huang P.

Cancer Cell. 2006 Sep;10(3):241-52.

6.

Monitoring chemotherapy-induced cardiotoxicity: role of cardiac nuclear imaging.

Panjrath GS, Jain D.

J Nucl Cardiol. 2006 May-Jun;13(3):415-26. Review.

PMID:
16750786
7.

Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death.

Swift LP, Rephaeli A, Nudelman A, Phillips DR, Cutts SM.

Cancer Res. 2006 May 1;66(9):4863-71.

8.

Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.

Zhang Y, Gu J, Zhao L, He L, Qian W, Wang J, Wang Y, Qian Q, Qian C, Wu J, Liu XY.

Cancer Res. 2006 Apr 15;66(8):4291-8.

9.

Relationships between genomic, cell cycle, and mutagenic responses of TK6 cells exposed to DNA damaging chemicals.

Islaih M, Halstead BW, Kadura IA, Li B, Reid-Hubbard JL, Flick L, Altizer JL, Thom Deahl J, Monteith DK, Newton RK, Watson DE.

Mutat Res. 2005 Oct 15;578(1-2):100-16.

PMID:
16109433
10.

Doxorubicin increases intracellular hydrogen peroxide in PC3 prostate cancer cells.

Wagner BA, Evig CB, Reszka KJ, Buettner GR, Burns CP.

Arch Biochem Biophys. 2005 Aug 15;440(2):181-90.

11.

Accelerated degradation of caspase-8 protein correlates with TRAIL resistance in a DLD1 human colon cancer cell line.

Zhang L, Zhu H, Teraishi F, Davis JJ, Guo W, Fan Z, Fang B.

Neoplasia. 2005 Jun;7(6):594-602.

12.

Rapid turnover of c-FLIPshort is determined by its unique C-terminal tail.

Poukkula M, Kaunisto A, Hietakangas V, Denessiouk K, Katajamäki T, Johnson MS, Sistonen L, Eriksson JE.

J Biol Chem. 2005 Jul 22;280(29):27345-55. Epub 2005 May 10.

14.

Apoptosis and cell recovery in response to oxidative stress in p53-deficient prostate carcinoma cells.

Bataller M, Portugal J.

Arch Biochem Biophys. 2005 May 15;437(2):151-8. Epub 2005 Mar 19.

PMID:
15850555
15.

Toxicity of the topoisomerase II inhibitors.

Seiter K.

Expert Opin Drug Saf. 2005 Mar;4(2):219-34. Review.

PMID:
15794715
17.

An IAP-IAP complex inhibits apoptosis.

Dohi T, Okada K, Xia F, Wilford CE, Samuel T, Welsh K, Marusawa H, Zou H, Armstrong R, Matsuzawa S, Salvesen GS, Reed JC, Altieri DC.

J Biol Chem. 2004 Aug 13;279(33):34087-90. Epub 2004 Jun 24.

18.
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk